Astellas Pharma, Inc. revenue for the last year amounted to 10.20 B USD, the most of which — 11.09 B USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 11.21 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Astellas Pharma, Inc. 4.59 B USD, and the year before that — 4.81 B USD.